IDRA Idera Pharmaceuticals Inc

Price (delayed)

$1.06

Market cap

$53.04M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.89

Enterprise value

$9.4M

Highlights
IDRA's equity has soared by 146% QoQ
The net income has surged by 89% since the previous quarter and by 68% year-on-year
The company's gross profit has shrunk by 100% YoY
Idera Pharmaceuticals's revenue has shrunk by 100% YoY

Key stats

What are the main financial stats of IDRA
Market
Shares outstanding
50.03M
Market cap
$53.04M
Enterprise value
$9.4M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.06
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$11.87M
EBITDA
-$11.82M
Free cash flow
-$32.62M
Per share
EPS
-$0.89
Free cash flow per share
-$0.79
Book value per share
$1
Revenue per share
$0
TBVPS
$1.17
Balance sheet
Total assets
$48.01M
Total liabilities
$5.7M
Debt
$904,000
Equity
$42.3M
Working capital
$42.02M
Liquidity
Debt to equity
0.02
Current ratio
9.41
Quick ratio
8.92
Net debt/EBITDA
3.69
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-30.1%
Return on equity
N/A
Return on invested capital
-670%
Return on capital employed
-27.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDRA stock price

How has the Idera Pharmaceuticals stock price performed over time
Intraday
1.92%
1 week
0.95%
1 month
-9.4%
1 year
-50.23%
YTD
-71.12%
QTD
-11.67%

Financial performance

How have Idera Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$33.56M
Net income
-$11.87M
Gross margin
N/A
Net margin
N/A
The company's gross profit has shrunk by 100% YoY
Idera Pharmaceuticals's revenue has shrunk by 100% YoY
The net income has surged by 89% since the previous quarter and by 68% year-on-year
Idera Pharmaceuticals's operating income has increased by 30% YoY and by 9% from the previous quarter

Growth

What is Idera Pharmaceuticals's growth rate over time

Valuation

What is Idera Pharmaceuticals stock price valuation
P/E
N/A
P/B
1.06
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
IDRA's EPS has soared by 73% from the previous quarter and by 61% YoY
IDRA's equity has soared by 146% QoQ
Idera Pharmaceuticals's revenue has shrunk by 100% YoY

Efficiency

How efficient is Idera Pharmaceuticals business performance
Idera Pharmaceuticals's return on assets has surged by 90% QoQ and by 79% YoY

Dividends

What is IDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDRA.

Financial health

How did Idera Pharmaceuticals financials performed over time
Idera Pharmaceuticals's total liabilities has shrunk by 96% QoQ and by 85% YoY
The company's quick ratio has surged by 66% QoQ
IDRA's debt is 98% smaller than its equity
IDRA's equity has soared by 146% QoQ
IDRA's debt to equity has soared by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.